Amgen Names Michael Severino Corporate Chief Medical Officer

Amgen AMGN today announced that Michael Severino, M.D., has been named senior vice president, Global Development and Corporate Chief Medical Officer, effective immediately. Severino, 46, formerly vice president, Global Development at Amgen, will replace Sean Harper, M.D. Harper, 49, was appointed Amgen's executive vice president, Research and Development.